Anti-Müllerian hormone (AMH) is critical to the regression of Müllerian ducts during mammalian male differentiation and targets ovarian granulosa cells and testicular Sertoli and Leydig cells of adults. Specific effects of AMH are exerted via its receptor, AMH type II receptor (Amhr2), but the mechanism by which the Amhr2 gene is specifically activated is not fully understood. To see whether a proximal promoter was sufficient for Amhr2 gene activation, we generated transgenic mice that bore the enhanced green fluorescent protein (EGFP) gene driven by a 500-bp mouse Amhr2 gene promoter. None of the established 10 lines, however, showed appropriate EGFP expression, indicating that the 500-bp promoter was insufficient for Amhr2 gene activation. As a regulatory element, we found a long noncoding RNA, lncRNA-Amhr2, transcribed from upstream of the Amhr2 gene in ovarian granulosa cells and testicular Sertoli cells. In primary granulosa cells, knockdown of lncRNA-Amhr2 resulted in a decrease of Amhr2 messnger RNA level, and a transient reporter gene assay showed that lncRNA-Amhr2 activation increased Amhr2 promoter activity. The activity was correlated with lncRNA-Amhr2 transcription in stably transfected OV3121 cells derived from mouse granulosa cells. Moreover, by the Tet-on system, the induction of lncRNA-Amhr2 transcription dramatically increased Amhr2 promoter activity in OV3121 cells. These results indicate that lncRNA-Amhr2 plays a role in Amhr2 gene activation in ovarian granulosa cells by enhancing promoter activity, providing insight into Amhr2 gene regulation underlying the AMH signaling in the female reproductive system. (Endocrinology 158: 4105-4121, 2017) 
A nti-Müllerian hormone (AMH) is a glycoprotein that induces the regression of Müllerian ducts during male differentiation in embryos (1, 2) and controls the folliculogenesis and Leydig cell proliferation in the adult ovary and testis (3, 4) . Its actions are mediated by type I and type II receptors that form a heterodimer, leading to activation of the Smad signaling pathway (5) . Because the type I receptor is an activin-like kinase that is expressed in various tissues (5) , it is the AMH type II receptor (Amhr2) that determines the specificity of AMH actions. In mammals, the Amhr2 gene is highly expressed in embryonic and postnatal gonads, especially in ovarian granulosa cells and testicular Sertoli cells (6) (7) (8) (9) , although Leydig cells also express it (10, 11) . Such specific activation of the Amhr2 gene is essential to sex differentiation and adult reproductive functions (12) .
In the adult ovary, AMH is secreted from granulosa cells of preantral follicles and exhibits inhibitory effects on the entry of primordial follicles into the growing phase and on the sensitivity of antral follicles to folliclestimulating hormone (4, 13) . When the AMH signaling is disturbed, the ovulation ceases at a younger age than usual (14) . Moreover, in humans, AMH is tightly associated with some ovarian dysfunction, such as polycystic ovarian syndrome and premature ovarian insufficiency (4, 13) , and the defect is caused by genetic mutations in the gene encoding AMH or its receptor (4) or by the aberrant regulation of AMH and AMHR2 without genetic mutations (15) . These findings, combined with the facts that the AMH gene is simply controlled by its promoter (16) (17) (18) and that Amhr2 is a major determinant of AMH actions, clearly underscore the importance of the regulatory mechanism of Amhr2 gene expression. Nevertheless, how the Amhr2 gene is controlled is not fully understood.
The regulatory mechanism of the AMHR2 gene was first reported in humans. The binding of a transcription factor, SF-1, to the AMHR2 proximal promoter and a synergistic effect of the b-catenin signaling pathway were shown to be important for gene activation (19, 20) . A recent study showed that bone morphogenetic protein 15 could also enhance AMHR2 promoter activity in granulosa cells (21) . In a rat Leydig cell line, a 1.6-kb Amhr2 promoter exhibited high activity, and two SF-1 binding sites in the proximal region were critical (22) . In mouse, a transcription factor, WT-1, binds to the Amhr2 proximal promoter and plays a crucial role in gene activation during development (23) . The chicken AMHR2 gene was recently cloned and found to be positively and negatively regulated by the DMRT1 gene and estrogen, respectively (24) . Although all these studies focused on the proximal promoter, it is not known whether the promoter is really sufficient for specific activation of the Amhr2 gene and whether any other regulatory elements exist.
Many genes require regulatory elements other than proximal promoters, such as distal enhancers and long noncoding RNAs (lncRNAs), to be fully and specifically activated (25) (26) (27) . Especially, lncRNAs have recently received much attention because of their variability and abundance (28) . lncRNAs are defined as RNAs that are longer than 200 nucleotides and function as RNA molecules without being translated (28) . In many cases, lncRNA transcripts are important for their functions, but at some loci, noncoding transcription per se is effective independently of the resulting transcripts (29, 30) . Studies have shown that lncRNAs are key regulators in many biological fields, such as immunology, development, and neurobiology, by functioning through gene regulation at various levels (i.e., transcription, RNA stability, RNA degradation, and translation) (31) (32) (33) (34) (35) . In the field of endocrinology, lncRNAs are known to participate in hormonal control (36) (37) (38) (39) (40) (41) and regulate the genes encoding hormones and hormone receptors (30, (42) (43) (44) (45) . Therefore, more lncRNAs are presumed to be associated with hormonal control or regulation of hormone/hormone receptor gene expression.
In this study, we assessed whether a proximal promoter was sufficient for Amhr2 gene activation by generating transgenic mice. We found that a 500-bp promoter was insufficient for specific gene activation. We then identified an lncRNA, lncRNA-Amhr2, which was transcribed in correlation with Amhr2. By knockdown and a series of experiments using reporter genes, lncRNAAmhr2 was found to enhance Amhr2 promoter activity in ovarian granulosa cells. The results provide insight into Amhr2 gene regulation.
Materials and Methods

Animals
C57/B6 and BDF1 (C57/B6 3 DBA2 F1) mice were maintained at 25°C with a photoperiod of 14 hours light and 10 hours dark. Eight tissues (i.e., brain, heart, liver, kidney, ovary, spleen, testis, and uterus) were collected from male and/or female mice. Food and water were freely accessed. Experimental procedures used in this study were approved by the Institutional Animal Use and Care Committee at Hokkaido University.
Plasmid constructs
0.5k-enhanced green fluorescent protein
A 500-bp sequence of the mouse Amhr2 promoter was amplified by polymerase chain reaction (PCR) with mouse genome DNA and KOD polymerase (Toyobo, Osaka, Japan) using a primer pair of 5 0 -CTACACAGAGAAACCCTGTC-3 0 and 5 0 -CCTCAGCCAAGGCTTCCTA-3 0 . The product was subcloned into a pBluescript II vector (Stratagene, La Jolla, CA) at the EcoRV site, and the resulting plasmid was checked by a DNA sequencing method. This plasmid was digested with HindIII and EcoRI, and a 0.5-kb fragment was blunted and inserted into a p-enhanced green fluorescent protein (pEGFP) 1 vector (Clontech, Palo Alto, CA) at the blunted BamHI site.
sh-lncAmhr2
A double-stranded DNA was generated by annealing 5 0 -GATCCGCAGAAAGCATGTCCATATGAGTGTGCTGTC-CTCATATGGACATGCTTTCTGCTTTTTTA-3 0 and 5 0 -AGCT-TAAAAAAGCAGAAAGCATGTCCATATGAGGACAGCA-CACTCATATGGACATGCTTTCTGCG-3 0 oligonucleotides. The DNA was inserted into a pBAsi-mU6 Neo DNA vector (Takara, Kusatsu, Japan) at BamHI and HindIII sites. The construct was checked by a DNA sequencing method.
0.5k-Luc
A 500-bp Amhr2 promoter sequence was obtained as described and subcloned into a pGL3-Basic vector (Promega, Madison, WI) at the blunted HindIII site.
6.1k-Luc
The 0.5k-Luc construct was digested with BglII, and a 607-bp fragment, which was obtained by digestion of a B6N mouse BAC clone, B6Ng01-240N22 (RIKEN Bioresource Center, Tsukuba, Japan) with BglII, was inserted. The resulting vector was named 1.0k-Luc. A 6.0-kb fragment was obtained by digestion of B6Ng01-240N22 with EcoRI and subcloned into a pBluescript II vector at the EcoRI site. The plasmid was digested with EcoRI and NheI, and a 5126-bp fragment was inserted into 1.0k-Luc at the EcoRI-NheI site.
6.1k-toER-Luc
A 1.8-kb complementary DNA (cDNA) sequence of torazame estrogen receptor (ER) was subcloned into a pcDNA3.1 vector (Invitrogen, Carlsbad, CA) (46) . The plasmid was digested with EcoRI, and the 1.8-kb ER fragment was purified, blunted, and inserted into 6.1k-Luc, which was digested with AflII and Tth111I and blunted.
6.1k-DlncPr-Luc
The 6.1k-Luc construct was digested with EcoRV and Tth111I, blunted, and self-ligated.
6.1k-POPpr-Luc
A 914-bp mouse prolyl oligopeptidase (POP) gene promoter was subcloned into a pEGFP-1 vector (Clontech) (47, 48) . The plasmid was digested with BamHI and EcoRI, and the POP promoter was purified, blunted, and inserted into 6.1k-Luc, which was digested with EcoRV and Tth111I and blunted.
RevPOPpr-Luc and POPpr-Luc
The blunted 914-bp POP promoter prepared as described was inserted into pGL3-Basic, which was digested with SmaI.
RevPOPpr-0.5k-Luc and POPpr-0.5k-Luc
The blunted 914-bp POP promoter prepared as described was inserted into 0.5k-Luc, which was digested with SmaI.
6.1k-POPpr-toER-Luc
The blunted 914-bp POP promoter prepared as described was inserted into pcDNA3.1 containing toER cDNA, which was digested with BamHI and blunted. The resulting plasmid was digested with NotI and KpnI, and a 2.7-kb fragment was purified, blunted, and inserted into 6.1k-Luc, which was digested with EcoRV and AflII and blunted.
6.1k-EGFP
A 1130-bp Amhr2 promoter was amplified by PCR with mouse genome DNA and KOD FX Neo (Toyobo), using a primer pair of 5 0 -CTCTCCATCCCAAGTTGGTT-3 0 and 5 0 -CCTCAGC-CAAGGCTTCCTA-3 0 , and digested with KpnI. The resulting 0.8-kb fragment was subcloned into a pEGFP-1 vector (Clontech) at the KpnI-SmaI site, and the plasmid was named 0.8k-EGFP. 6.1k-Luc was digested with KpnI, and a 5.3-kb fragment was purified and inserted into 0.8k-EGFP at the KpnI site.
6.1k-toER-EGFP
The 6.1k-toER-Luc construct was digested with KpnI, and a 5.3-kb fragment was purified and inserted into 0.8k-EGFP at the KpnI site.
6.1k-POPpr-EGFP
The 6.1k-POPpr-Luc construct was digested with KpnI, and a 5.3-kb fragment was purified and inserted into 0.8k-EGFP at the KpnI site.
6.1k-TO-Luc
A 459-bp hCMV*1 promoter sequence, which was responsive to doxycycline (Dox), was obtained by digestion of the pPBhCMV*1-cHA-pA plasmid (49) with SacII and AccI. The hCMV*1 promoter was blunted and inserted into 6.1k-Luc at the blunted Tth111I site.
Transgenic mouse generation
Transgenic mice were generated as previously described (48) . The 0.5k-EGFP plasmid was digested with XhoI and AflII, purified to exclude the vector sequence, and injected into fertilized eggs. Twelve founders were obtained by dot blot analysis of tail DNAs with an EGFP fragment (772 bp) as a probe. The probe was prepared by digestion of pEGFP-1 vector with EcoRI and NotI. All founders were mated with wild-type mice and 10 lines were established. Copy numbers of the established lines were determined by Southern blot analysis with genome DNAs digested with DraI and PvuII, using an EcoRI-NotI EGFP fragment as a probe. A 422-bp probe, which was amplified from the Amhr2 gene body by genome PCR using primers of 5 0 -ACATCTTCTCCAGGCTGGCA-3 0 and 5 0 -CCAAGTGGATGGGATGTTG-3 0 , was used as a control of two copies. The procedure of Southern blot was previously described (50) .
Reverse transcription PCR and quantitative reverse transcription PCR RNA isolation, DNase treatment, and reverse transcription followed by PCR (RT-PCR) or quantitative PCR (qPCR) were performed as previously described (50) (51) (52) (53) . Reverse transcription was performed with a specific primer for lncRNAAmhr2 in Fig. 1(A) and with the oligo(dT) primer in the other experiments. In qPCR, detection of lncRNA-Amhr2 was done with KOD SYBR qPCR Mix (Toyobo); for the other transcripts, Power SYBR Green Master Mix (Life Technologies, Foster City, CA) was used. Primer sequences for these experiments are listed in Table 1 .
Cell sorting
The tunica albuginea was removed from testes of adult #326 mice and placed in Dulbecco's modified Eagle medium (DMEM) containing 0.5 mg/mL collagenase. The seminiferous tubules were cut into small pieces and incubated in a 33°C water bath for 30 minutes with occasional agitation. The cells were dispersed by gentle pipetting and filtrated through a cell strainer tube (Falcon 352235; Corning Inc., Corning, NY) to remove seminiferous tubules. The cells were separated by EGFP intensity, and the EGFP-positive cells were sorted by JSAN cell sorter (Bay Bioscience, Kobe, Japan). OV3121 cells transfected with 6.1k-EGFP were also sorted into EGFP-positive and -negative populations.
Isolation and culture of primary Sertoli and granulosa cells
Primary Sertoli cells were isolated from 8-to 12-day-old male mice and cultured on collagen-coated dishes as previously described (54) . Briefly, testes were decapsulated and treated with 0.1% collagenase at 32°C twice for 15 to 20 minutes, and the sedimented tubules were washed with phosphate-buffered saline containing 1 mM EDTA three times. The tubules were cut into small pieces, and germ cells and Sertoli cells were dispersed by pipetting them. The dispersed cells were washed with DMEM/F12 supplemented with 10% fetal bovine serum (FBS) three times and spread onto 24-well dishes that were coated with collagen. After culturing for 1 day at 32°C, the cells were treated with 10 mM Tris-HCl (pH 7.4) for 3 minutes to eliminate germ cells, and the attached Sertoli cells were cultured for several days.
Primary granulosa cells were isolated from immature female mice that had been given hormones, and the cells were cultured in fibronectin-coated dishes as previously described (51) . Briefly, 3-to 4-week-old female mice were administered pregnant-mare serum gonadotropin and human chorionic gonadotropin to induce follicular growth.
Five hours after the injection of human chorionic gonadotropin, ovaries were collected, and follicles were punctured by needles in DMEM/F12 with 10% FBS. The cells were washed with the medium three times and spread onto 24-well fibronectin-coated dishes. They were cultured at 37°C for several days.
Table 1. Oligonucleotide Primers Used for RT-PCR and qRT-PCR Designation
Forward Reverse
RT-PCR followed by electrophoresis Amhr2
RT-PCR with a specific primer for RT Primer for RT
Tissue-specificity of lncRNA-Amhr2 was investigated by RT-PCR analysis. Eight tissues were isolated from wild-type mice, and RT-PCR was performed by using a specific primer for reverse transcription (RT) of lncRNA-Amhr2 and oligo(dT) for Gapdh. We used a primer pair that could amplify all four variants of lncRNA-Amhr2. The signal was specifically observed in the ovary and testis.
Gapdh was amplified as an internal control. The cycle numbers were 40 for lncRNA-Amhr2 and 27 for Gapdh. (B) RT-PCR with primary cells. Sertoli cells were isolated from testes of 8-to 12-day-old male mice and cultured on collagen-coated dishes for several days. Primary granulosa cells were isolated from ovaries of immature female mice after administration with hormones and cultured on fibronectin-coated dishes for several days. Total RNAs were purified from these cells, and RT-PCR analysis was performed as in Fig. 2 
(B).
Amhr2 was detected as a positive control. The cycle number was 35. (C) Subcellular distribution of lncRNA-Amhr2 was investigated by RT-PCR. Primary granulosa cells were cultured and fractionated into cytoplasmic and nuclear fractions. Total RNA was purified from each fraction (Cytoplasmic and Nuclear) as well as granulosa cells without fractionation (Total), and RT-PCR was performed as described. A primer pair to amplify a part of exon 6 of the Gapdh gene was used as a control. The lncRNA-Amhr2 signal was exclusively detected in the nuclear fraction. The cycle numbers were 35 for lncRNAAmhr2 and 30 for Gapdh.
Fractionation into cytoplasmic and nuclear fractions
Fractionation of primary granulosa cells into cytoplasmic and nuclear fractions followed by RT-PCR analysis was performed as previously described (52) .
Rapid amplification of cDNA ends 5 0 rapid amplification of cDNA ends (RACE) and 3 0 RACE were performed with total RNAs from ovarian granulosa cells and the testis, as previously described (52, 53) . The first PCR product was diluted 1:1000 and used for the second PCR. Ten subclones for each RACE product were checked by a DNA sequencing method. Primers used for RACE analyses are listed in Table 2 .
Knockdown of lncRNA-Amhr2
sh-lncAmhr2 or pBAsi-mU6 Neo DNA plasmids were transfected into primary granulosa cells using GeneJuice transfection reagent (Merck, Darmstadt, Germany) according to the manufacturer's instruction. Two days later, 1 mg/mL G418 was added to the medium and the cells were cultured for another 4 days. Then, total RNAs were purified with ISOGEN II (Nippongene, Tokyo, Japan), and RNA levels were assessed by quantitative RT-PCR (qRT-PCR).
Reporter gene assay by transient transfection
Constructs containing the luciferase gene were transfected into primary granulosa or Sertoli cells with a pRL-CMV vector (Promega) using GeneJuice (Merck) or Genefectine (Genetrone Biotech, Seoul, South Korea) transfection reagents. Two days later, the cells were lysed and firefly luciferase activity was measured as previously described (51) . Transfection efficiency was normalized by measuring Renilla luciferase activity that was derived from pRL-CMV.
Culture and establishment of OV3121 cells stably transfected with pEGFP plasmids OV3121 cells derived from mouse granulosa cells were obtained from the Japanese Collection of Research Bioresources cell bank (National Institutes of Biomedical Innovation, Health and Nutrition), and cultured in DMEM supplemented with 10% FBS, 100 U/mL penicillin, 100 mg/mL streptomycin, and 292 mg/mL L-glutamine. The 0.5k-EGFP construct was linearized by digestion with XhoI, and 6.1k-EGFP, 6.1k-toER-EGFP, and 6.1k-POPpr-EGFP were digested with MluI. The linearized constructs were transfected into OV3121 cells using GeneJuice transfection reagent and, 2 days later, selection was started by adding 0.5 mg/mL G418 to the medium. Because the pEGFP-1 vector contained the neomycin-resistant gene, transfection of these constructs generated neomycin-resistant cells. A 500-bp Amhr2 promoter is insufficient for specific gene activation in granulosa and Sertoli cells. Transgenic mice were generated with the 0.5k-EGFP construct in which the EGFP gene was driven by a 500-bp Amhr2 promoter. (A) Fluorescent microscopic images of testes from a wildtype mouse (WT) and a #326 mouse. (B) RT-PCR analysis of the EGFP reporter gene in three transgenic mouse lines. Eight tissues were collected from the indicated transgenic mouse lines, #326, #321, and #348, and total RNAs were purified from them. cDNAs were synthesized with (RT+) or without reverse transcription (RT2) using the oligo(dT) primer, and PCR was performed with primer pairs for the indicated genes. The cycle numbers were 30 for Amhr2 and EGFP and 24 for Gapdh. Testis-specific amplification was observed in the #326 line. (C) qRT-PCR analysis of the EGFP gene in cell fractions before (Total) and after sorting (EGFP+). Testicular cells were isolated from testes of #326 mice, and green cells were collected by a cell sorter. Total RNAs were purified from the cells before and after the sorting, and cDNAs were synthesized using the olig(dT) primer. qPCR was performed to detect marker genes for Leydig cells (Hsd3b), germ cells (Ddx4/Vasa), and Sertoli cells (Sgp2), using the 7300 qPCR system (Applied Biosystems). PCR was also performed for a housekeeping gene, Gapdh, and the data were normalized to the Gapdh level. The value in the cells before sorting (Total) was set to 1.0, and relative levels of the marker genes after sorting are shown. The EGFP-positive fraction was enriched in germ cells. The data are presented as mean 6 standard deviation from four independent experiments with two sets of sorted cells, and the statistical significance was analyzed by Student t test. *P , 0.05; **P , 0.01.
The cells were cultured for another 10 to 14 days, and resulting survived cells were used for experiments.
Establishment of stably transfected OV3121 cells for Tet-on system and Dox treatment
The 6.1k-TO-Luc plasmid was linearized by digestion with MluI, and transfected into OV3121 cells with pPBCAGrtTA-IN and pPyCAG-PBase plasmids (49) using GeneJuice transfection reagent. pPBCAGrtTA-IN was a piggyBac-based construct, and by transposase activity from pPyCAG-PBase, the rtTA gene would be efficiently integrated into the genome of OV3121 cells. Two days after transfection, 0.5 mg/mL G418 was added to the medium, and the cells were cultured for another 12 days. For Dox treatment, the cells were spread on 35-mm dishes, and 1 mg/mL Dox was added to the medium on the next day. At 5 hours and 24 hours after the addition of Dox, the cells were collected with ISOGEN II for qRT-PCR and with Passive Lysis Buffer (Promega) for luciferase assay. qRT-PCR was done as already described, and luciferase activity was measured with LARII (Promega), using Lumat LB9507 (Berthold, Bad Wildbad, Germany). Protein concentration of the cell lysate was measured with a Pierce Bicinchoninic Acid Protein Assay Reagent Kit (Thermo Fisher Scientific, Waltham, MA) according to the manufacturer's instruction. Luciferase activity was normalized to the concentration.
Statistical analysis
The data are presented as mean 6 standard deviation. Statistical comparison was made by Student t test or one-way analysis of variance followed by Tukey-Kramer test. P , 0.05 was considered statistically significant.
Results
A 500-bp promoter was insufficient for Amhr2 gene activation
We obtained a 500-bp proximal promoter sequence by genomic PCR, based on the transcriptional start site (TSS) determined in rat and aligned to the mouse Amhr2 locus (22, 23) . This sequence contained the binding sites for SF1 and WT1 that were reported to be critical to Amhr2/ AMHR2 gene activation (23) . We successfully established 10 transgenic lines bearing the EGFP gene driven by the 500-bp promoter, and the copy number was determined to range from one to 25 (Table 3) . We first checked whether green fluorescence was observed in the ovary and testis for all the lines, but most lines showed no fluorescence and only the testis from line #326 was green [ Table 3 ; Fig. 2(A) ]. To check the EGFP messenger RNA (mRNA) expression in adult tissues, we picked three representative lines, #321, #326, and #348, and performed RT-PCR with eight adult tissues. We detected no EGFP signals in any tissues of line #321 and faint bands in brain, heart, and spleen of line #348, whereas in line #326, a specific signal was observed in the testis [ Fig. 2(B) ]. These suggested that the transgene was integrated into an active chromatin region in the testis of #326. Thus, we checked embryos of #326 but did not observe any green fluorescence in gonads or urogenital regions in E12.5 to E15.5 (Table 3) .
We next pursued the possibility that EGFP was specifically activated in somatic cells in the testis of #326. To determine which types of cells expressed EGFP, we dispersed the #326 testis, collected somatic and germ cells together, and sorted them by green fluorescence using a cell sorter. We investigated the expression of marker gene for each type of testicular cells: Hsd3b for Leydig cells, Ddx4/ Vasa for germ cells, and Sgp2 for Sertoli cells (55) . qRT-PCR showed that EGFP-positive cells included both somatic cells and germ cells and were enriched in germ cells, which was inconsistent with the Amhr2 expression enriched in Fig. 2(C)] . Thus, the data demonstrated that in #326, the 500-bp promoter did not reproduce the Amhr2 expression pattern. Collectively, the proximal promoter was insufficient for Amhr2 gene activation, which suggested the presence of other regulatory elements.
Identification and characterization of lncRNA-Amhr2
In the process of searching for regulatory elements, we found noncoding transcription occurred in an upstream region of the Amhr2 gene, and we named the transcript lncRNA-Amhr2. RT-PCR using eight tissues showed that lncRNA-Amhr2 was specifically detected in the ovary and testis, as with the Amhr2 gene [ Fig. 1(A) ]. To check whether the cell type expressing lncRNA-Amhr2 coincided with Amhr2, we isolated and cultured primary granulosa and Sertoli cells and performed RT-PCR. The purity of these cell fractions was confirmed by qRT-PCR for marker genes in the testis and ovary (Supplemental Fig. 1 ). The lncRNA signal was detected in both types of cells [ Fig. 1(B) ], showing coexpression of lncRNAAmhr2 and Amhr2. We then examined the subcellular localization of lncRNA-Amhr2 by RT-PCR with nuclear and cytoplasmic fractions from granulosa cells, and observed the signal in the nucleus but not in the cytoplasm [ Fig. 1(C) ]. These data suggested the role of lncRNAAmhr2 in Amhr2 gene activation, and we decided to determine the full length of this lncRNA.
The direction of the noncoding transcription was opposite to Amhr2, as determined by RT-PCR with specific primers for reverse transcription (data not shown), so we attempted to determine the full length in that direction. RACE analyses were performed with total RNAs from primary granulosa cells and the testis, and we identified tissue-specific TSSs by 5 0 RACE. In granulosa cells, two nucleotides were identified as TSSs by examining 10 subclones [ Fig. 3(A) and 3(B) ]. In the testis, we obtained two bands after the second PCR, and each contained one TSS [ Fig. 3(A) and 3(C) ]. By 3 0 RACE, we identified 10 transcriptional termination sites (TTSs) within a GA-rich region, and a guanine was determined to be the major one because it was a TTS in more subclones than any other sites [ Fig. 3(D) ]. Thus, we report an lncRNA, namely lncRNA-Amhr2, which was coexpressed with Amhr2, and we identified two variants in ovarian granulosa cells and two in the testis [ Fig. 3(A) ]. The length of the variants was 1655 to 2099 nucleotides, and the longest one in the testis contained one intron, whereas the other variants were a single exon gene. Although many lncRNAs were not evolutionarily conserved (33) , lncRNA-Amhr2 contained conserved noncoding sequences when we compared the mouse Amhr2 locus with the human genome [ Fig. 3(A) ], using the mVista program (http://genome.lbl.gov/vista/ index.shtml). Nucleotide sequence data for these four lncRNA-Amhr2 variants were deposited to DDBJ/EMBL/ GenBank databases (LC274966, LC274967, LC274968, and LC274969).
Knockdown of lncRNA-Amhr2 decreased Amhr2 expression in primary granulosa cells
The coexpression of lncRNA-Amhr2 and Amhr2 prompted us to explore the possibility of a mechanism for Amhr2 gene activation by lncRNA-Amhr2. Thus, we attempted to knock down lncRNA-Amhr2 in primary granulosa and Sertoli cells. However, the knockdown did not work in Sertoli cells, and we could only obtain the result with granulosa cells. By transfection with the sh-lncAmhr2 construct and selection with G418 in primary granulosa cells, the lncRNA-Amhr2 level was decreased by approximately 60% compared with the control [ Fig. 4(A) ]. The endogenous Amhr2 expression was significantly decreased to approximately 50% that of the control, whereas Nr5a1/Sf1 and Actb mRNA levels were not changed by this knockdown [ Fig. 4B-4D) ]. This indicated that lncRNA-Amhr2 specifically contributed to Amhr2 gene activation in granulosa cells.
lncRNA-Amhr2 activation increased Amhr2 promoter activity in primary granulosa cells
To see whether lncRNA-Amhr2 activated the Amhr2 gene by enhancing its promoter activity, we generated five constructs [ Fig. 5(A) ]. We obtained a 6.1-kb upstream sequence of the Amhr2 gene and connected to the luciferase gene (6.1k-Luc). Then, we replaced most of the lncRNAAmhr2 sequence with torazame ER cDNA, which was similar in length (6.1k-toER-Luc) (46) , and the lncRNAAmhr2 promoter sequence with the POP promoter (6.1k-POPpr-Luc). The replacement with torazame ER would result in transcription of a sequence unrelated to lncRNAAmhr2, and the POP promoter was known to show strong promoter activity in various types of cells and expected to drive lncRNA-Amhr2 transcription at a higher level than other constructs (47, 48, 51) . As controls, we also prepared the constructs that contained the 0.5-kb Amhr2 promoter (0.5k-Luc) and lacked a lncRNA-Amhr2 promoter sequence (6.1k-DlncPr-Luc).
We transiently transfected primary granulosa cells with these constructs as well as a control vector bearing no promoter (pGL3-Basic), and measured the luciferase activity. 0.5k-Luc showed significantly higher activity than 6.1k-Luc [ Fig. 5(A) ], which was consistent with previous studies reporting that a shorter sequence often possessed higher promoter activity in transient assay (56) (57) (58) (59) . The replacement of lncRNA with torazame ER Fig. 5(C) ]. These excluded the possibility that the reporter gene expression was increased by bidirectional promoter activity or enhancer activity of the POP promoter. In addition, we replaced both the lncRNA sequence and lncRNA promoter with torazame ER and the POP promoter (6.1k-POPpr-toER-Luc), and found that the activation of torazame ER transcription did not significantly increase Amhr2 promoter activity [ Fig. 5(D) ]. These indicated that lncRNA-Amhr2 activation increased Amhr2 promoter activity in granulosa cells.
In Sertoli cells, we observed significantly higher activity in 0.5k-Luc, similar to granulosa cells (Fig. 6) . However, no significant difference was detected among the other constructs, even if 6.1k-POPpr-Luc showed higher activity (Fig. 6) . Therefore, we conducted further experiments only with granulosa cells.
lncRNA-Amhr2 transcription correlated with Amhr2 promoter activity in stably transfected OV3121 cells
In the primary culture system, we could only perform transient transfection. We next investigated whether the lncRNA-Amhr2 transcription also contributed to activation of the Amhr2 promoter when the construct was integrated into genomic DNA. For this purpose, we used OV3121 cells that were derived from mouse granulosa cell tumor and expected to maintain some properties as granulosa cells (60) . Here, we used the EGFP gene as a reporter and prepared four constructs: 0.5k-EGFP (the construct used for generating transgenic mice), 6.1k-EGFP, 6.1k-toER-EGFP, and 6.1k-POPpr-EGFP [ Fig. 7(A) and 7(B) ]. We transfected the constructs into OV3121 cells, established stable cells by the selection with G418, and checked expression of lncRNA-Amhr2 Fig. 1(B) and transfected with a vector containing shRNA for lncRNA-Amhr2 (Knock down) or a control vector (Control). The cells were selected by adding G418 to the culture medium for several days. Total RNAs were purified from the cells, and qRT-PCR was performed for expression of (A) lncRNA-Amhr2, (B) Amhr2, (C) Nr5a1/Sf1, and (D) Actb. The expression level was normalized to Gapdh, and the value in the control sample was set to 1.0. lncRNA-Amhr2 was successfully knocked down, and Amhr2 expression was significantly decreased. The data are presented as mean 6 standard deviation from four independent experiments, and the statistical significance was analyzed by Student t test. *P , 0.05; **P , 0.01. doi: 10.1210/en.2017-00619 https://academic.oup.com/endo Two days after the transfection, cell lysates were collected and luciferase activity was measured. Relative luciferase activity is shown in the bar graph. The data are presented as mean 6 standard deviation (SD) from three or five independent experiments. Luciferase activity was significantly higher in 6.1k-POPpr-Luc than other constructs containing the 6.1-kb sequence. (B) Unidirectional activity of the POP promoter. The POP promoter was directly connected to the luciferase gene in both directions, and the constructs were transfected into primary granulosa cells. Luciferase activity was measured and shown as in Fig. 5(A) . The data are presented as mean 6 SD from four independent experiments. The POP promoter in the forward direction exhibited much higher activity. (C) The effect of the POP promoter on Amhr2 promoter activity. The POP promoter was connected to upstream of the 0.5-kb Amhr2 promoter in 0.5k-Luc, and luciferase activity was assessed in primary granulosa cells. The data are presented as mean 6 SD from four independent experiments. The POP promoter in the reverse direction had no significant effect on Amhr2 promoter activity. (D) The effect of the torazame ER sequence driven by the POP promoter on Amhr2 promoter activity. lncRNA-Amhr2 and its promoter sequence were replaced with torazame ER and the POP promoter. Luciferase assay was performed in primary granulosa cells as and EGFP mRNA by qRT-PCR. lncRNA-Amhr2 transcripts were detected at a significantly higher level in the cells with 6.1k-POPpr-EGFP than those with 6.1k-EGFP [ Fig. 7(A) ]. This showed that the POP promoter actually drove the lncRNA-Amhr2 transcription more strongly than the original promoter. The other two constructs resulted in no lncRNA-Amhr2 transcripts, as expected To further confirm the relationship between lncRNA and EGFP, we concentrated EGFP-positive cells using a cell sorter and performed RT-PCR. As a result, lncRNA-Amhr2 transcripts were detected in EGFP-positive cells at a much higher level than in EGFP-negative cells [ Fig. 7(D) ]. This clearly indicated that the lncRNA-Amhr2 transcription was well correlated with Amhr2 promoter activity when the construct was integrated into genome DNA and supported that lncRNA-Amhr2 contributed to Amhr2 activation.
Induction of lncRNA-Amhr2 transcription increased
Amhr2 promoter activity Finally, we attempted to clarify whether the lncRNAAmhr2 transcription could enhance Amhr2 promoter activity, using the Tet-on system. We inserted the hCMV*1 promoter that was responsive to Dox into a restriction site at approximately 100-bp downstream to TSSs of lncRNAAmhr2 ovary variants in 6.1k-Luc [ Fig. 8(A) ]. This construct was expected to induce the transcription of most of the lncRNA-Amhr2 sequence in response to Dox. We transfected OV3121 cells with this construct and selected the cells that were integrated with the transgene into genomic DNA. We added Dox to the selected cells, and at 5 hours and 24 hours later, the lncRNA-Amhr2 transcription was examined. By qRT-PCR, the lncRNA-Amhr2 level was about 30-fold higher in the cells treated with Dox than in the control cells at both time points [ Fig. 8(B) ]. This indicated that the induction of lncRNA-Amhr2 transcription was successful, so we checked the luciferase gene expression by qRT-PCR and luciferase activity assay. The luciferase mRNA level was 5.4-fold and 4.3-fold higher at 5 hours and 24 hours, respectively, after the addition of Dox than in the control cells [ Fig. 8(C) ], and luciferase activity was 6.9-and 12.5-fold higher with Dox than the control at the two respective time points [ Fig. 8(D) ]. These data indicated that the induction of lncRNA-Amhr2 transcription enhanced Amhr2 promoter activity and increased the luciferase gene expression. Therefore, we concluded that lncRNA-Amhr2 controlled the Amhr2 gene through enhancing its promoter activity in ovarian granulosa cells.
Discussion
We first assessed in vivo activity of an Amhr2 proximal promoter by generating transgenic mice. The EGFP Figure 5 . (Continued). in Fig. 5(A) . The data are presented as mean 6 SD from four independent experiments. Torazame ER transcription by the POP promoter did not significantly increase Amhr2 promoter activity. For all the data, the statistical significance was analyzed by one-way analysis of variance followed by Tukey-Kramer test. **P , 0.01. Figure 6 . Reporter gene assay in primary Sertoli cells. Primary Sertoli cells were cultured, and transfection and luciferase activity assay were performed as in Fig. 5(A) . The data are presented as mean 6 standard deviation from five or six independent experiments. The use of POP promoter had no significant effect on the Amhr2 promoter. The statistical significance was analyzed by one-way analysis of variance followed by Tukey-Kramer test. **P , 0.01. doi: 10.1210/en.2017-00619 https://academic.oup.com/endofluorescence was not observed and the RT-PCR signal was not detected in the ovary and testis of transgenic lines except for the testis of #326 ( Fig. 2 ; Table 3 ). This suggests that the transgene was integrated into genomic regions where the chromatin was tightly packed in the nine lines except for #326, and that the 500-bp promoter does not contain any elements to open the chromatin. In addition, the majority of green cells from the #326 testis were found to be germ cells rather than somatic cells, and embryonic gonads were not green in this line. This further suggests that the transgene does not contain any elements to restrict the expression of a linked reporter gene to testicular somatic cells, even if it is inserted into a genomic region that was specifically activated in the testis. We could still obtain some green Sertoli and Leydig cells and the promoter might be partly responsible for this activation, but, obviously, the 500-bp sequence could not specify the expression to somatic cells in the testis. Collectively, our data clearly show that the 500-bp promoter does not reproduce the Amhr2 expression in vivo; in other words, the proximal promoter is insufficient for Amhr2 gene activation. Given that reporter genes were expressed in mostly identical patterns to Amhr2 when integrated into exon 5 of the native Amhr2 gene (61, 62) , other regulatory elements could be present at the locus, and we found lncRNA-Amhr2 as an element responsible for Amhr2 activation at least in granulosa cells.
We have provided the following evidence supporting the regulation of Amhr2 by lncRNA-Amhr2. First, knockdown of lncRNA-Amhr2 led to a decrease in the Amhr2 mRNA level in primary granulosa cells (Fig. 4) . This, together with the data showing that the activation of torazame ER transcription did not increase Amhr2 promoter activity (Fig. 5) , also revealed that it was the lncRNA-Amhr2 transcript but not noncoding transcription per se that was required for gene activation. Second, the transient reporter gene assay showed that lncRNA-Amhr2 activation by the POP promoter significantly increased Amhr2 promoter activity in primary granulosa cells (Fig. 5) . Third, higher lncRNA-Amhr2 transcription increased Amhr2 promoter activity even when the transgene was integrated into the genome DNA of granulosa cell-derived OV3121 cells (Fig. 7) . Fourth, in those stable OV3121 cells, the EGFP reporter gene was Figure 8 . Induction of lncRNA-Amhr2 transcription increased Amhr2 promoter activity in the Tet-on system. (A) A schematic drawing of the 6.1k-TO-Luc construct for establishing the Tet-on inducible system. A 6.1-kb upstream region of the Amhr2 gene was connected to the luciferase gene, and the hCMV*1 promoter was inserted to induce the transcription of most of the lncRNA-Amhr2 sequence. (B-D) OV3121 cells were transfected with the construct and selected with G418. The established stable cells were treated with (Dox+) or without Dox (Dox2) for 5 or 24 hours, and total RNAs and protein extracts were collected. Using the total RNAs, qRT-PCR was performed to measure (B) lncRNA-Amhr2 and (C) luciferase mRNA levels. Gapdh was used as an internal control. The protein extracts were used for luciferase activity assay and bicinchoninic acid (BCA) assay. The luciferase enzymatic activity was normalized to the value by BCA assay, and (D) relative activity is shown as a graph. lncRNA-Amhr2 transcription was successfully induced by Dox, and luciferase expression was dramatically increased. The data are presented as mean 6 standard deviation from (B, C) three or (D) six independent experiments. Student t test was performed to analyze the statistical significance. *P , 0.05; **P , 0.01; ***P , 0.001. activated only in the cell population expressing lncRNAAmhr2 at high levels. Fifth, the induction of lncRNAAmhr2 transcription by the Tet-on system dramatically increased activity of the linked Amhr2 promoter in stably transfected OV3121 cells (Fig. 8) . These results indicate that lncRNA-Amhr2 plays an important role in Amhr2 gene activation in ovarian granulosa cells, and, therefore, this lncRNA is a regulatory element of the mouse Amhr2 gene.
In contrast to granulosa cells, the knockdown experiment did not work in Sertoli cells, similar to some nuclear lncRNAs that were not efficiently knocked down with short hairpin RNAs (63, 64) . Additionally, the use of the POP promoter for lncRNA-Amhr2 transcription did not result in a significant increase of Amhr2 promoter activity in primary Sertoli cells. However, these do not necessarily mean that lncRNA-Amhr2 is not involved in Amhr2 regulation in this cell lineage. We observed still-higher Amhr2 promoter activity in the cells with 6.1k-POPpr-Luc than 6.1k-Luc, 6.1k-toER-Luc, and 6.1k-DlncPr-Luc (Fig. 6) , suggesting a positive role for lncRNA-Amhr2 in Sertoli cells. Alternatively, it may be possible that an intron-containing variant [e.g., testis variant 2 in Fig. 3(A) ] activates the Amhr2 gene by a different mechanism in Sertoli cells. Further analyses will be required for revealing the function of lncRNA-Amhr2 in Sertoli cells.
lncRNAs control their target genes on the same chromosome in cis or on another chromosome in trans. Our data strongly suggest that lncRNA-Amhr2 acts on the Amhr2 gene only in cis, which is consistent with many lncRNAs controlling linked protein-coding genes (26) . In transgenic mice, the exogenous Amhr2 promoter was not activated in the ovary of all 10 lines, despite the presence of endogenous lncRNA-Amhr2 transcripts in granulosa cells. If lncRNA-Amhr2 acted in trans, we could have observed the EGFP activation in their ovaries. In addition, our preliminary data showed that Amhr2 expression was not influenced by overexpression of lncRNAAmhr2 in some types of cultured cells (unpublished data). Thus, lncRNA-Amhr2 is likely to act only in cis. Cis-acting lncRNAs generally need to interact with the chromatin region of their target gene loci (33, 65) , and the endogenous lncRNA-Amhr2 might not be able to reach genome regions integrated with the transgenes.
In general, lncRNAs are categorized by their localization and functional mechanisms, and lncRNA-Amhr2 belongs to those localized in the nucleus and involved in gene activation in cis. There are some categories for such lncRNAs: enhancer RNAs, activating RNAs, and promoter-associated noncoding RNAs. Enhancer RNAs are transcribed bidirectionally from enhancers and mediate the chromatin looping to allow the enhancers to physically contact their target promoters (66, 67) . Activating RNAs bind to mediators and promote the target gene transcription (26, 68) , and promoter-associated noncoding RNAs are located just upstream to their target gene promoters to control epigenetic modifications (69) . lncRNA-Amhr2 is similar to activating RNAs in that it is transcribed from a neighboring region of its target, activates the target gene in cis, and the transcript is required. Thus, lncRNA-Amhr2 may activate the Amhr2 gene by a mechanism similar to activating RNAs.
This study revealed that an lncRNA, lncRNA-Amhr2, contributes to Amhr2 gene activation in mouse ovarian granulosa cells. AMH is an important hormone for the regulation of folliculogenesis in the ovary, and the Amhr2 protein is a pivotal molecule to mediate the signaling. Given that the down-and upregulation of this receptor gene results in abnormal folliculogenesis (14, 70, 71) , lncRNA-Amhr2 is highly likely to be a key molecule controlling AMH signaling, probably via interacting with the Amhr2 promoter in cis and the consequent upregulation of the Amhr2 gene. Notably, one of the transcription factors for Amhr2 activation, WT-1, binds to the proximal promoter of the Amhr2 gene and has RNAbinding activity in embryonic stem cells (72, 73) . In combination, current results support the view that lncRNA-Amhr2 interacts with transcription factors binding to the Amhr2 promoter to activate this gene. Further investigation of the molecular mechanism of the Amhr2 activation and the physiologic functions in the regulation of endocrine system by lncRNA-Amhr2 is underway.
In conclusion, we demonstrated that a proximal promoter was insufficient for Amhr2 gene activation in vivo and identified an lncRNA, lncRNA-Amhr2, that plays a role in Amhr2 gene activation in ovarian granulosa cells. The study reveals a mechanism of Amhr2 gene activation, and provides insight into the regulation of AMH signaling. Matsubara 
